19-Oct-2025 ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
19-Oct-2025 Study finds protein target that predicts drug resistance in colon cancer The Hebrew University of Jerusalem Peer-Reviewed Publication
19-Oct-2025 Drug combo cuts risk of death in advanced prostate cancer by 40% Cedars-Sinai Medical Center Peer-Reviewed Publication
19-Oct-2025 ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors Dana-Farber Cancer Institute Reports and Proceedings
18-Oct-2025 ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
18-Oct-2025 Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer Dana-Farber Cancer Institute Reports and Proceedings
18-Oct-2025 ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
18-Oct-2025 New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease European Society for Medical Oncology Reports and Proceedings
17-Oct-2025 Sylvester Cancer Tip Sheet for October 2025 University of Miami Miller School of Medicine Peer-Reviewed Publication
17-Oct-2025 Scientists discover how leukemia cells evade treatment Rutgers University Peer-Reviewed Publication